These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6099768)

  • 1. Influence of intracerebroventricular (ICV) GTP-electrolyte infusion on ICV (D-ALA2, D-LEU5) enkephalin (DADL)-induced cardiovascular effects in rats.
    McDonald WJ; Notter M; Ganten D; Lang RE
    Clin Exp Hypertens A; 1984; 6(10-11):1837-41. PubMed ID: 6099768
    [No Abstract]   [Full Text] [Related]  

  • 2. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
    Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
    Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13).
    Ukai M; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(1):32-7. PubMed ID: 2894701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma catecholamine and cardiovascular responses to morphine and D-ala2-d-leu5-enkephalin in conscious rats.
    Conway EL; Brown MJ; Dollery CT
    Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):244-58. PubMed ID: 6360061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of an opioid-evoked vagal reflex in rats by naloxone, SMS 201-995 and ICI 154, 129.
    Kiang JG; Wei ET
    Regul Pept; 1983 Jul; 6(3):255-62. PubMed ID: 6137865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock.
    Feuerstein G; Powell E; Faden AI
    Peptides; 1985; 6 Suppl 1():11-3. PubMed ID: 2995939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterograde transport of opioid receptors in rat vagus nerves and dorsal roots of spinal nerves: pharmacology and sensitivity to sodium and guanine nucleotides.
    Zarbin MA; Wamsley JK; Kuhar MJ
    Exp Brain Res; 1990; 81(2):267-78. PubMed ID: 1697808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
    Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
    Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of codeine-7,8-oxide (codeine-epoxide), as a new metabolite of codeine, with multiple opiate receptors.
    Konno F; Sato Y; Togashi K; Takayanagi I; Hirobe M
    Gen Pharmacol; 1985; 16(4):379-81. PubMed ID: 2995195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mu, delta, kappa and epsilon opioid receptor agonists on heart rate and blood pressure of the pithed rat.
    Eimerl J; Feuerstein G
    Neuropeptides; 1986; 8(4):351-8. PubMed ID: 2881224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance and cross tolerance to morphine after chronic spinal D-Ala2-D-Leu5-enkephalin infusion.
    Tseng LF
    Life Sci; 1982 Sep; 31(10):987-92. PubMed ID: 6752616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial cross tolerance to D-Ala2-D-Leu5-enkephalin after chronic spinal morphine infusion.
    Tseng LF
    Life Sci; 1983 May; 32(22):2545-50. PubMed ID: 6304439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [D-Ala2,Leu5,Cys6]enkephalin: short-term agonist effects and long-term antagonism at delta opioid receptors.
    Calcagnetti DJ; Fanselow MS; Helmstetter FJ; Bowen WD
    Peptides; 1989; 10(2):319-26. PubMed ID: 2547203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose- and strain-dependent effects of dermorphin and [D-Ala2-D-Leu5]enkephalin on passive avoidance behavior in mice.
    Castellano C; Pavone F
    Behav Neurosci; 1985 Dec; 99(6):1120-7. PubMed ID: 2886135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
    Tseng LF; Cheng SS; Fujimoto JM
    J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of D-ala2, D-Leu5-enkephalin injections into the nucleus accumbens on the motility of rats.
    Havemann U; Winkler M; Kuschinsky K
    Life Sci; 1983; 33 Suppl 1():627-30. PubMed ID: 6363855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanine nucleotide and cation regulation of mu, delta, and kappa opioid receptor binding: evidence for differential postnatal development in rat brain.
    Szücs M; Spain JW; Oetting GM; Moudy AM; Coscia CJ
    J Neurochem; 1987 Apr; 48(4):1165-70. PubMed ID: 3029328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat.
    Feuerstein G; Faden AI
    Life Sci; 1982 Nov 15-22; 31(20-21):2197-200. PubMed ID: 6131355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus.
    Hassen AH; Feuerstein G; Faden AI
    Neuropharmacology; 1984 Apr; 23(4):407-15. PubMed ID: 6328352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.